VRTX
Vertex Pharmaceuticals Inc
508.30$
-1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -88.4% | -35.4% | 13.9% | 34.0% | 41.7% | 37.7% | 52.4% | 34.9% | 46.2% | 35.8% | -4.5% | 30.1% | |
| 10.9% | 6.0% | 3.6% | 2.5% | 2.4% | 2.6% | 1.8% | 1.7% | 1.7% | 1.8% | 1.9% | 1.7% | |
| 30.6% | 22.4% | 14.0% | 11.7% | 10.7% | 8.7% | 6.9% | 5.8% | 5.5% | 5.9% | 6.3% | 5.7% | |
| 30.5% | 23.5% | 14.3% | 32.0% | 12.6% | 9.2% | 8.4% | 6.0% | 5.0% | – | – | – | |
| -1.9% | -8.3% | -0.1% | 0.6% | 7.8% | -1.6% | -0.9% | -1.4% | 3.8% | -2.7% | -4.7% | -9.9% | |
| 8.8% | 4.4% | 3.3% | 10.4% | 3.1% | 1.8% | 4.2% | 3.1% | 2.3% | 2.6% | 2.7% | 3.6% | |
| 12.7% | 26.0% | 6.1% | -17.6% | -6.6% | -29.7% | 1.6% | -4.5% | -3.6% | -31.8% | -34.2% | -7.8% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.7% | 0.2% | 4.3% | 1.3% | – | – | – | – | |
| 47.3% | 18.0% | 4.0% | 13.9% | -11.5% | -4.6% | -11.9% | -20.6% | -1.9% | -4.3% | -10.7% | -16.7% | |
| 48.4% | 0.4% | -0.6% | -11.4% | -0.2% | -0.8% | -0.5% | -0.3% | -1.0% | -0.5% | -0.3% | 0.0% | |
| 85.7% | 18.3% | 7.8% | 2.7% | -2.3% | 3.0% | -8.1% | -19.5% | -0.8% | -5.7% | -13.6% | -18.7% | |
| 9.6% | 8.7% | 27.6% | 19.3% | 32.5% | 11.1% | 46.2% | 10.7% | 41.6% | -1.4% | -52.6% | 4.3% | |
| -97.2% | -39.8% | 10.5% | 23.5% | 38.5% | 35.9% | 48.2% | 31.8% | 44.0% | 33.2% | -7.2% | 26.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.